Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Histochem ; 62(3)2018 Sep 03.
Article in English | MEDLINE | ID: mdl-30362671

ABSTRACT

Breast cancer is a very heterogeneous disease. The intrinsic molecular subtypes can explain the intertumoral heterogeneity and the cancer stem cell (CSC) hypothesis can explain the intratumoral heterogeneity of this kind of tumor. CD44+/CD24- phenotype and ALDH1 expression are the major CSC markers described in invasive breast cancer. In the present study, 144 samples of invasive breast carcinoma, no special type were distributed in 15 tissue microarrays (TMA) and then evaluated for expression of the CD44+/CD24- phenotype and ALDH1 to understand the importance of these CSC markers and the clinical aspects of breast cancer. The samples were classified into four molecular subtypes according to clinicopathological criteria: Luminal A, Luminal B, HER2, and Basal-like. A statistical association was found between the molecular subtypes and the CSC markers, with HER2 the most frequent subtype for both markers. ALDH1 was also associated with other poor prognostic variables, such as a high histological grade and larger tumors, but it was not associated with the patients' prognosis in this sample and nor was the CD44+/CD24- phenotype in a multivariate analysis. There are still many controversies about the role of these markers in breast cancer molecular subtypes. The identification of these populations of cells, through immunohistochemical markers, can help to better understand the CSC theory in clinical practice and, in the near future, contribute to developing new target therapies.


Subject(s)
Biomarkers, Tumor/chemistry , CD24 Antigen/blood , Carcinoma, Ductal, Breast/classification , Carcinoma, Ductal, Breast/diagnosis , Hyaluronan Receptors/blood , Isoenzymes/chemistry , Lymphatic Metastasis/pathology , Retinal Dehydrogenase/chemistry , Adult , Aged , Aged, 80 and over , Aldehyde Dehydrogenase 1 Family , Female , Humans , Immunohistochemistry , Middle Aged , Multivariate Analysis , Phenotype , Prognosis
2.
Breast J ; 8(4): 253-7, 2002.
Article in English | MEDLINE | ID: mdl-12100121

ABSTRACT

The sentinel node concept agrees with the modern principles of surgical oncology in breast cancer, which are related to lymphatic dissection, accurate axillary study, and less traumatic surgery. After publication of many series, it has proven its capacity to correctly stage axilla and select patients who need axillary dissection. The Brazilian Society of Senology established the current norms for its practice. However, the transportation of new surgical techniques from research to practice always occurs with some ethical dilemmas related to its introduction in clinical practice. The aim of this study was to analyze the ethical challenges of the sentinel node technique and problems with its implementation.


Subject(s)
Breast Neoplasms/pathology , Ethics, Medical , Sentinel Lymph Node Biopsy , Female , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...